Cannabis, popularly known as Marijuana, is the most commonly used illicit drug after alcohol. More than 150 Million people regularly smoke marijuana. Approximately 11.8 Million young adult American populations consumed marijuana in 2017 estimated the results of a survey by the National Survey on Drug Use and Health.
Cannabis is widely used to alleviate pain such as neuropathic pain, fibromyalgia, rheumatoid arthritis, and mixed chronic pain. Marijuana is also in use to treat a number of different conditions such as glaucoma, hiv/aids symptoms, multiple sclerosis, muscle spasms, and Dravet syndrome. Medical marijuana is also helpful in treating nausea and vomiting associated with cancer chemotherapy, certain forms of epilepsy and Lennox-Gastaut syndrome.
Several pharmaceutical companies are involved in exploring the potential that the medical marijuna market offers. Companies including MedReleaf, Tetra Bio-Pharma, TO Pharmaceuticals, and several others are proactively testing different strains of marijuana for different indications.
An influx of companies, the launch of pipeline therapies, and the legalization of marijuana/ cannabis are the major drivers of the medical marijuana market.
For more detailed information on Marijuana Market Size and Growth, visit: https://www.delveinsight.com/blog/medical-marijuana-market/